Treatment-Related Cystitis During Intravesical Chemotherapy: Incidence and Risk Factors

A retrospective, single-center observational cohort study analyzed 120 consecutive patients receiving intravesical chemotherapy for non-muscle-invasive bladder cancer. The study quantified a 45.8% incidence of treatment-related cystitis (TRC) and identified associated clinical and procedural factors. Authored by Jiali Zhang and last updated in May 2026, the dataset compares outcomes under standard care versus a preventive nursing pathway.

Use Cases

• Modeling the risk of treatment-related cystitis based on procedural timing and catheterization attempts mentioned in the description
• Evaluating the association between structured nursing pathways and adverse event rates
• Analyzing treatment interruption patterns attributable to post-instillation symptoms

Strengths

• Contains data on 120 consecutive patients, providing a defined cohort size.
• Reports specific, adjusted odds ratios (e.g., aOR = 0.54) for key associations.
• Documents a clear outcome measure: TRC assessed within 7 days after each instillation.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The study design is non-randomized and from a single center, which may limit generalizability.

Provenance

Source

figshare

Collection Method

Retrospective analysis of electronic medical records from a single center.

Freshness

Last updated 2026-05-17 13:13:03; freshness should be verified.